share_log

Teachers Retirement System of The State of Kentucky Sells 1,921 Shares of Masimo Co. (NASDAQ:MASI)

Teachers Retirement System of The State of Kentucky Sells 1,921 Shares of Masimo Co. (NASDAQ:MASI)

肯塔基州教師退休制度出售Masimo Co.(納斯達克代碼:MASI)1,921股
Defense World ·  2022/09/24 05:21

Teachers Retirement System of The State of Kentucky reduced its stake in shares of Masimo Co. (NASDAQ:MASI – Get Rating) by 22.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,826 shares of the medical equipment provider's stock after selling 1,921 shares during the quarter. Teachers Retirement System of The State of Kentucky's holdings in Masimo were worth $993,000 at the end of the most recent quarter.

根據肯塔基州教師退休系統公司向美國證券交易委員會(SEC)提交的最新Form 13F文件,該公司在第一季度減持了Masimo Co.(納斯達克代碼:MASI-GET評級)的股票22.0%。該基金在本季度出售了1,921股後,持有這家醫療設備提供商的6826股股票。肯塔基州教師退休制度在最近一個季度末,肯塔基州在馬西莫的資產價值99.3萬美元。

Several other hedge funds have also modified their holdings of the stock. BlackRock Inc. lifted its holdings in Masimo by 1.5% in the fourth quarter. BlackRock Inc. now owns 9,026,374 shares of the medical equipment provider's stock valued at $2,642,740,000 after buying an additional 133,072 shares during the period. Vanguard Group Inc. lifted its holdings in Masimo by 1.5% in the first quarter. Vanguard Group Inc. now owns 4,775,660 shares of the medical equipment provider's stock valued at $695,050,000 after buying an additional 71,918 shares during the period. State Street Corp lifted its holdings in Masimo by 1.6% in the first quarter. State Street Corp now owns 1,730,991 shares of the medical equipment provider's stock valued at $251,928,000 after buying an additional 27,261 shares during the period. RTW Investments LP lifted its holdings in Masimo by 32.7% in the first quarter. RTW Investments LP now owns 1,127,593 shares of the medical equipment provider's stock valued at $164,110,000 after buying an additional 277,622 shares during the period. Finally, Liontrust Investment Partners LLP acquired a new position in Masimo in the first quarter valued at approximately $146,646,000. 93.31% of the stock is owned by institutional investors.

其他幾家對衝基金也調整了對該股的持有量。貝萊德股份有限公司去年第四季度增持馬西莫股份1.5%。貝萊德股份有限公司目前持有這家醫療設備供應商9,026,374股股票,價值2,642,740,000美元,在此期間又購買了133,072股。先鋒集團(Vanguard Group Inc.)第一季度增持Masimo股份1.5%。先鋒集團現在持有這家醫療設備供應商4,775,660股股票,價值695,050,000美元,在此期間又購買了71,918股。道富銀行在第一季度增持了1.6%的Masimo股份。道富集團目前持有這家醫療設備提供商1,730,991股股票,價值251,928,000美元,在此期間又購買了27,261股。RTW Investments LP在第一季度增持了32.7%的Masimo股份。RTW Investments LP現在擁有這家醫療設備提供商1,127,593股票,價值164,110,000美元,在此期間又購買了277,622股票。最後,LionTrust Investment Partners LLP在第一季度收購了Masimo的一個新頭寸,價值約為146,646,000美元。93.31%的股票由機構投資者持有。

Get
到達
Masimo
馬西莫
alerts:
警報:

Analyst Ratings Changes

分析師評級發生變化

MASI has been the topic of several analyst reports. Wolfe Research upgraded shares of Masimo from a "peer perform" rating to an "outperform" rating and set a $165.00 price objective on the stock in a report on Thursday, September 15th. StockNews.com lowered shares of Masimo from a "buy" rating to a "hold" rating in a report on Wednesday, August 10th. Piper Sandler raised their price objective on shares of Masimo from $135.00 to $150.00 and gave the stock a "neutral" rating in a report on Friday. Needham & Company LLC raised their price objective on shares of Masimo from $163.00 to $179.00 and gave the stock a "buy" rating in a report on Wednesday, August 10th. Finally, Loop Capital initiated coverage on shares of Masimo in a report on Tuesday, September 13th. They set a "buy" rating and a $206.00 price objective on the stock. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Masimo has an average rating of "Moderate Buy" and an average target price of $194.50.

馬西一直是幾份分析師報告的主題。沃爾夫研究公司在9月15日(星期四)的一份報告中將Masimo的股票評級從“同業表現”上調至“表現優於大盤”,併為該股設定了165.00美元的目標價。在8月10日星期三的一份報告中,StockNews.com將Masimo的股票評級從買入下調至持有。派珀·桑德勒在上週五的一份報告中將馬西莫股票的目標價從135.00美元上調至150.00美元,並給予該股“中性”評級。Needham&Company LLC將Masimo的股票目標價從163.00美元上調至179.00美元,並在8月10日星期三的一份報告中給出了該股的“買入”評級。最後,Loop Capital在9月13日星期二的一份報告中啟動了對Masimo股票的報道。他們為該股設定了“買入”評級和206.00美元的目標價。三位研究分析師對該股的評級為持有,五位分析師對該公司的評級為買入。根據MarketBeat的數據,Masimo的平均評級為“中等買入”,平均目標價為194.50美元.

Masimo Stock Down 0.1 %

Masimo股價下跌0.1%

Masimo stock opened at $142.28 on Friday. The company has a market cap of $7.47 billion, a P/E ratio of 42.86 and a beta of 0.96. Masimo Co. has a 1-year low of $112.07 and a 1-year high of $305.21. The company has a fifty day simple moving average of $149.18 and a 200 day simple moving average of $141.22. The company has a current ratio of 2.10, a quick ratio of 1.28 and a debt-to-equity ratio of 0.77.
上週五,馬西莫的股票開盤報142.28美元。該公司市值為74.7億美元,市盈率為42.86倍,貝塔係數為0.96。Masimo Co.的股價為一年低點112.07美元,一年高位為305.21美元。該公司的50日簡單移動均線切入位為149.18美元,200日簡單移動均線切入位為141.22美元。該公司的流動比率為2.10,速動比率為1.28,債務權益比率為0.77。

Masimo (NASDAQ:MASI – Get Rating) last announced its quarterly earnings data on Tuesday, August 9th. The medical equipment provider reported $1.35 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.16. Masimo had a net margin of 12.68% and a return on equity of 17.39%. The company had revenue of $565.30 million during the quarter, compared to the consensus estimate of $540.56 million. During the same quarter last year, the firm posted $0.94 EPS. The company's quarterly revenue was up 87.9% on a year-over-year basis. Research analysts anticipate that Masimo Co. will post 4.47 earnings per share for the current fiscal year.

馬西莫(納斯達克:MASI-GET評級)上一次公佈季度收益數據是在8月9日(星期二)。這家醫療設備供應商公佈本季度每股收益為1.35美元,比分析師普遍預期的1.19美元高出0.16美元。Masimo的淨利潤率為12.68%,股本回報率為17.39%。該公司本季度營收為5.653億美元,而市場普遍預期為5.4056億美元。去年同期,該公司公佈的每股收益為0.94美元。該公司季度營收同比增長87.9%。研究分析師預計,Masimo Co.本財年每股收益將達到4.47歐元。

About Masimo

關於馬西莫

(Get Rating)

(獲取評級)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Masimo公司在全球開發、製造和營銷非侵入性監測技術和醫院自動化解決方案。該公司提供Masimo信號提取技術(SET)脈搏血氧儀和低灌注脈搏血氧儀監測,以解決傳統脈搏血氧儀的主要侷限性。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on Masimo (MASI)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • 2 Semiconductor Stocks To Watch For Reversals
  • 免費獲取StockNews.com關於馬西莫(Masi)的研究報告
  • MarketBeat:回顧一週9/19-9/23
  • 為什麼特斯拉的股票保持彈性?
  • 好市多盈利後價格疲軟是買入的好時機嗎?
  • 小盤股的裁員是樓市的晴雨表嗎?
  • 需要關注的2只半導體類股走勢逆轉

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

接受Masimo Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Masimo和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論